Array of Clinical Trials in Biosimilars

A clinical trial is an examination study that tests another restorative treatment or another method for utilizing a current treatment to check whether it will be a superior approach to counteract and screen for analyse or treat a disease1. For any new medication to enter in clinical trial, it must pass preclinical studies. Preclinical studies  of Biosimilars include in vitro (i.e. test-tube or Laboratory) studies and trials on creature populaces. Extensive variety of measurements of the study medication is given to creature subjects or to an in-vitro substrate with a specific end goal to acquire preparatory adequacy, poisonous quality and pharmacokinetic data and includes Preclinical Studies in Phase I-IV.

  • Non-Clinical Studies in biosimilars development
  • Biosimilars development and impact on clinical practice
  • Optimising biosimilar clinical trial design
  • Preclinical and Clinical Development

Related Conference of Array of Clinical Trials in Biosimilars

June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Baltimore, Maryland, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

Array of Clinical Trials in Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in